Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 22

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Refinement of metabolite detection in cystic fibrosis sputum reveals heme correlates with lung function decline

Glasser, Nathaniel R., Hunter, Ryan C., Liou, Theodore G., Newman, Dianne K., for the Mountain West CF Consortium Investigators · 2019 · PLOS ONE

Published version of a preprint

Abstract

The bacterial growth environment within cystic fibrosis (CF) sputum is complex, dynamic, and shaped by both host and microbial processes. Characterization of the chemical parameters within sputum that stimulate the in vivo growth of airway pathogens (e.g. Pseudomonas aeruginosa) and their associated virulence factors may lead to improved CF treatment strategies. Motivated by conflicting reports of the prevalence and abundance of P. aeruginosa-derived metabolites known as phenazines within CF airway secretions, we sought to quantify these metabolites in sputum using quadrupole time-of-flight mass spectrometry. In contrast to our previous work, all phenazines tested (pyocyanin (PYO), phenazine-1-carboxylic acid (PCA), phenazine-1-carboxamide, and 1-hydroxyphenazine) were below detection limits of the instrument (0.1 μM). Instead, we identified a late-eluting compound that shared retention time and absorbance characteristics with PCA, yet generated mass spectra and a fragmentation pattern consistent with ferriprotoporphyrin IX, otherwise known as heme B. These data suggested that UV-vis chromatographic peaks previously attributed to PCA and PYO in sputum were mis-assigned. Indeed, retrospective analysis of raw data from our prior study found that the heme B peak closely matched the peaks assigned to PCA, indicating that the previous study likely uncovered a positive correlation between pulmonary function (percent predicted forced expiratory volume in 1 second, or ppFEV1) and heme B, not PCA or any other phenazine. To independently test this observation, we performed a new tandem mass-spectrometry analysis of 71 additional samples provided by the Mountain West CF Consortium Sputum Biomarker study and revealed a positive correlation (ρ = -0.47, p<0.001) between sputum heme concentrations and ppFEV1. Given that hemoptysis is strongly associated with airway inflammation, pulmonary exacerbations and impaired lung function, these new data suggest that heme B may be a useful biomarker of CF pathophysiology.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0226578

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 22

  1. F Harrison, 2007, Microbial ecology of the cystic fibrosis lung, Microbiol, 153, 917, 10.1099/mic.0.2006/004077-0 · DOI · Paper page
  2. SD Aaron, 2015, A statistical model to predict one-year risk of death in patients with cystic fibrosis, J Clin Epidemiol, 68, 1336, 10.1016/j.jclinepi.2014.12.010 · DOI
  3. GW Lau, 2004, Pseudomonas aeruginosa pyocyanin is critical for lung infection in mice, Infect Immunity, 72, 4275, 10.1128/IAI.72.7.4275-4278.2004 · DOI · Paper page
  4. RA Quinn, 2015, Microbial, host and xenobiotic diversity in the cystic fibrosis sputum metabolome, ISME J, 10, 1483, 10.1038/ismej.2015.207 · DOI
  5. RC Hunter, 2012, Phenazine content in the cystic fibrosis respiratory tract negatively correlates with lung function and microbial complexity, Am J Resp Cell Mol Biol, 47, 738, 10.1165/rcmb.2012-0088OC · DOI · Paper page
  6. TG Liou, 2019, Prospective multicenter randomized patient recruitment and sample collection to enable future measurements of sputum biomarkers of inflammation in an observational study of cystic fibrosis, BMC Med Res Method, 19, 88, 10.1186/s12874-019-0705-0 · DOI
  7. DB Rubin, 1976, Inference and missing data, Biometrika, 64, 581, 10.1093/biomet/63.3.581 · DOI · Paper page
  8. S Létoffé, 2009, Bacteria capture iron from heme by keeping tetrapyrrol skeleton intact, Proc Nat Acad Sci USA, 106, 11719, 10.1073/pnas.0903842106 · DOI
  9. DB Morrison, 1941, The solubility and titration of hemin and ferrihemic acid, J Biol Chem, 137, 461, 10.1016/S0021-9258(19)56151-8 · doi:10.1016/s0021-9258(19)56151-8
  10. P Jorth, 2015, Regional Isolation Drives Bacterial Diversification within Cystic Fibrosis Lungs, Cell Host Microb, 18, 307, 10.1016/j.chom.2015.07.006 · DOI · Paper page
  11. ES Cowley, 2015, Pediatric cystic fibrosis sputum can be chemically dynamic, anoxic, and extremely reduced due to hydrogen sulfide formation, mBio, 6, e00767, 10.1128/mBio.00767-15 · DOI · Paper page
  12. HJ Fuchs, 1994, Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis, N Engl J Med, 331, 637, 10.1056/NEJM199409083311003 · DOI · Paper page
  13. T Das, 2015, Phenazine virulence factor binding to extracellular DNA is important for Pseudomonas aeruginosa biofilm formation, Sci Rep, 5, 8398, 10.1038/srep08398 · DOI · Paper page
  14. HR Rabin, 2004, Pulmonary exacerbations in cystic fibrosis, Ped Pulmonol, 37, 400, 10.1002/ppul.20023 · DOI · Paper page
  15. JU Barben, 2003, Major haemoptysis in children with cystic fibrosis: a 20-year retrospective study, J Cyst Fib, 2, 105, 10.1016/S1569-1993(03)00066-3 · DOI
  16. RC Hunter, 2013, Ferrous iron is a significant component of bioavailable iron in cystic fibrosis airways, mBio, 4, e00557, 10.1128/mBio.00557-13 · DOI · Paper page
  17. E Banin, 2005, Iron and Pseudomonas aeruginosa biofilm formation, Proc Nat Acad Sci USA, 102, 11076, 10.1073/pnas.0504266102 · DOI · Paper page
  18. S Moreau-Marquis, 2009, Tobramycin and FDA-Approved Iron Chelators Eliminate Pseudomonas aeruginosa Biofilms on Cystic Fibrosis Cells, Am J Resp Cell Mol Biol, 41, 305, 10.1165/rcmb.2008-0299OC · DOI · Paper page
  19. 2018, Cystic Fibrosis Foundation Patient Registry 2017 Annual Data Report
  20. M Matsumoto, 1998, Mersenne Twister: A 623-dimensionally Equidistributed Uniform Pseudo-random Number Generator, ACM Trans Model Comput Simul, 8, 3, 10.1145/272991.272995 · DOI · Paper page
  21. Standardization of Spirometry, 1994 Update, 1995, American Thoracic Society, Am J Resp Crit Care Med, 152, 1107
  22. JL Hankinson, 1999, Spirometric reference values from a sample of the general U.S. population, Am J Resp Crit Care Med, 159, 179, 10.1164/ajrccm.159.1.9712108 · DOI · Paper page

Cited by

See all 22

Metadata

Authors
Glasser, N. R., Hunter, R. C., Liou, T. G., Newman, D. K., & for the Mountain West CF Consortium Investigators
Venue
PLOS ONE
Published
2019-12-18
Volume
14
Issue
12
Pages
e0226578
ISSN
1932-6203
Cited by
22
References
3
Language
en
Funders
  • Cystic Fibrosis Foundation (LIOU13A0, LIOU14Y4)
  • National Center for Advancing Translational Sciences (NIH 8UL1TR000105)
  • Ben B. and Iris M. Margolis Foundation
  • National Heart, Lung, and Blood Institute (R01HL117328)
  • National Institute of Allergy and Infectious Diseases (R01AI127850)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Refinement of metabolite detection in cystic fibrosis sputum reveals heme correlates with lung function decline. https://app.cochat.ai/papers/10.1371/journal.pone.0226578
The paper
Glasser, N. R., Hunter, R. C., Liou, T. G., Newman, D. K., & for the Mountain West CF Consortium Investigators. (2019). Refinement of metabolite detection in cystic fibrosis sputum reveals heme correlates with lung function decline. PLOS ONE. https://doi.org/10.1371/journal.pone.0226578

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.